Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 04.11.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
04.11.23Berkshire Hathaway Inc.: Operating results for the third quarter and first nine months of 2023 and 2022240OMAHA, Neb.--(BUSINESS WIRE)--Berkshire's operating results for the third quarter and first nine months of 2023 and 2022 are summarized in the following paragraphs. However, we urge investors and reporters...
► Artikel lesen
04.11.23Adverum Biotechnologies, Inc.: Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023265- Patients in OPTIC continue to experience long-term benefit from Ixo-vec through 3 years of follow-up, including maintenance of vision, durability of anatomical improvements and sustained reduction...
► Artikel lesen
04.11.23Candel Therapeutics Presents Preclinical Data from its enLIGHTEN Discovery Platform at SITC263The first experimental agent from the enLIGHTEN Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate innate immune surveillanceApplication of the enLIGHTEN...
► Artikel lesen
04.11.23Gamida Cell, Ltd: Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting202BOSTON, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the company's...
► Artikel lesen
04.11.23Medigene AG: Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A11402Planegg/Martinsried, November 4, 2023. Medigene AG (Medigene, the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies...
► Artikel lesen
04.11.23Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023155Analysis of week 36 data from Phase 2b ORIGIN study shows atacicept 150 mg substantially reduces serum Gd-IgA1 and resolves hematuria in the majority of patients. Additional poster presentations...
► Artikel lesen
04.11.23BANK OF BARODA: FINANCIAL STATEMENTS & RELATED ANNOUNCEMENT: HALF YEARLY RESULTS-
04.11.23STATE BANK OF INDIA: FINANCIAL STATEMENTS & RELATED ANNOUNCEMENT: SECOND QUARTER AND/ OR HALF YEARLY RESULTS-
04.11.23Ausgeprägte US-Bankenschwäche - deutliches Warnsignal für Aktienmarkt181* Bankenpleiten sind Warnzeichen * Bank of America- und Citigroup-Aktien auf neuen Tiefs * Fortsetzung der Aktienbaisse Liebe Leser,Banken spielen in unserem Finanzsystem eine ganz entscheidende Rolle....
► Artikel lesen
04.11.23Striking actors reviewing 'final' offer from Hollywood studios1
04.11.23Discord file links will expire after a day to fight malware1
04.11.23BND vs. AGG: Comparing Bond ETFs2
04.11.23Tesla Chief Designer Seen In Matte Black Cybertruck21
04.11.23Schwesig beharrt auf hälftiger Beteiligung des Bundes am Deutschlandticket1
04.11.23Güterzug reißt Oberleitung herunter - 70 Menschen aus Personenzug evakuiert2
04.11.23Staatsanwaltschaft erhebt Anklage gegen Bahnmitarbeiter nach Waggonbrand1
04.11.23US-Außenminister bereist Nahost: Blinken: Waffenstillstand würde Hamas nutzen2
04.11.23Ursula von der Leyen in Kiew: Eine Ukraine-Reise gegen das Vergessen1
04.11.23Climate Negotiators Reach Framework to Aid Vulnerable Countries1
04.11.23Striking Hollywood actors receive 'last, best, and final offer' from studios1
Seite:  Weiter >>